Browse diseases

…n patients receiving pembrolizumab plus axitinib for metastatic renal cell carcinoma: preliminary results of the randomized phase II TACITO trial. A…

… analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. The Journal of Pathology. 2007;213(4):392–401.Su C, Lv Y, Lu W…

…apy has been tested in other solid tumour malignancies, such as renal cell carcinoma (29% ORR in 7 patients),49 non-small cell lung cancer (23% ORR …

…umour and immune adaptation during ICI therapy in patients with advanced RCC reported opposing findings where responder tumours showed incre…

…d; the mean age was 67.6±13.6 years. The primary diagnoses were Renal Cell Carcinoma (31%), Bladder Cancer (31%), and Melanoma (38%). 65 patients (4…

…dity of CAR-T cells to mitigate on-target off-tumor toxicity in renal cell carcinoma.Conclusions Cell Avidity is an emerging biomarker that directly…

…s might improve outcome for a broader spectrum of patients with cancer. Phosphoantigen-responsive Vγ9Vδ2-T cells are potent immune cel…

…Renal cell carcinoma is the most common renal tumour in adult that often metastasise…

…rs targeting CD70 show early promising results for their use in RCC in preclinical and clinical trials. However, further research a…

…econdary objectives.Results The study enrolled 12 patients with melanoma (n=9), head and neck squamous cell carcinoma (HNSCC; n=1), rena…

…ving CPI was 7% (535 patients). The highest incidence was among melanoma patients receiving combination therapy of ipilimumab and nivolu…

…Renal malignancy in ectopic fused pelvic kidneys is exceptionally rare, with onl…